Enfusion, Inc.
ENFN
$10.76
-$0.04-0.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -91.45% | -22.51% | 438.78% | -186.52% | -65.92% |
| Total Depreciation and Amortization | 11.99% | -6.75% | 6.29% | -37.42% | 55.06% |
| Total Amortization of Deferred Charges | 6.79% | 15.98% | 8.54% | 7.81% | 18.92% |
| Total Other Non-Cash Items | -3.47% | -15.55% | -13.50% | 60.21% | -15.77% |
| Change in Net Operating Assets | -94.26% | 218.61% | 48.01% | -215.60% | -288.33% |
| Cash from Operations | -40.15% | 120.97% | 377.10% | -76.72% | -45.60% |
| Capital Expenditure | 19.29% | -9.85% | -58.27% | 47.30% | -25.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.04% | 64.45% | -122.48% | -93.85% | 33.90% |
| Cash from Investing | 4.04% | 51.37% | -107.64% | -19.74% | 11.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 100.00% | -- | -- | -119.69% | 95.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 65.35% | -- | 100.00% |
| Cash from Financing | 100.00% | 12.50% | 98.83% | -137.13% | 89.09% |
| Foreign Exchange rate Adjustments | -273.07% | 1,328.21% | 68.03% | -150.83% | 177.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -55.38% | 791.95% | 157.31% | -168.57% | 1.83% |